Literature DB >> 7546601

Actinoplanic acids A and B as novel inhibitors of farnesyl-protein transferase.

K C Silverman1, C Cascales, O Genilloud, J M Sigmund, S E Gartner, G E Koch, M M Gagliardi, B K Heimbuch, M Nallin-Omstead, M Sanchez.   

Abstract

Actinoplanic acids A and B are macrocyclic polycarboxylic acids that are potent reversible inhibitors of farnesyl-protein transferase. Actinoplanic acids A and B were isolated from Actinoplanes sp. MA 7066 while actinoplanic acid B was isolated from both MA 7066 and Streptomyces sp. MA 7099. Actinoplanic acids A and B are competitive with respect to farnesyl diphosphate and are selective inhibitors of farnesyl-protein transferase because they do not inhibit geranylgeranyl-protein transferase type 1 or squalene synthase. MA 7066 is believed to be a novel species of actinomycetes while MA 7099 is believed to be a novel strain of Streptomyces violaceusniger on the basis of morphological, biochemical and chemotaxonomic characteristics as well as its production of actinoplanic acids.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7546601     DOI: 10.1007/bf00164762

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  25 in total

1.  Inhibition of farnesyl-protein transferase by gliotoxin and acetylgliotoxin.

Authors:  D Van der Pyl; J Inokoshi; K Shiomi; H Yang; H Takeshima; S Omura
Journal:  J Antibiot (Tokyo)       Date:  1992-11       Impact factor: 2.649

Review 2.  Protein isoprenylation and methylation at carboxyl-terminal cysteine residues.

Authors:  S Clarke
Journal:  Annu Rev Biochem       Date:  1992       Impact factor: 23.643

Review 3.  Regulation of the mevalonate pathway.

Authors:  J L Goldstein; M S Brown
Journal:  Nature       Date:  1990-02-01       Impact factor: 49.962

Review 4.  Inhibitors of Ras farnesyltransferases.

Authors:  F Tamanoi
Journal:  Trends Biochem Sci       Date:  1993-09       Impact factor: 13.807

5.  Characterization of recombinant human farnesyl-protein transferase: cloning, expression, farnesyl diphosphate binding, and functional homology with yeast prenyl-protein transferases.

Authors:  C A Omer; A M Kral; R E Diehl; G C Prendergast; S Powers; C M Allen; J B Gibbs; N E Kohl
Journal:  Biochemistry       Date:  1993-05-18       Impact factor: 3.162

6.  Selective inhibition of farnesyl-protein transferase blocks ras processing in vivo.

Authors:  J B Gibbs; D L Pompliano; S D Mosser; E Rands; R B Lingham; S B Singh; E M Scolnick; N E Kohl; A Oliff
Journal:  J Biol Chem       Date:  1993-04-15       Impact factor: 5.157

7.  Identification of Ras farnesyltransferase inhibitors by microbial screening.

Authors:  M Hara; K Akasaka; S Akinaga; M Okabe; H Nakano; R Gomez; D Wood; M Uh; F Tamanoi
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

8.  Protein farnesyltransferase inhibitors block the growth of ras-dependent tumors in nude mice.

Authors:  N E Kohl; F R Wilson; S D Mosser; E Giuliani; S J deSolms; M W Conner; N J Anthony; W J Holtz; R P Gomez; T J Lee
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

Review 9.  Isoprenoid modification and plasma membrane association: critical factors for ras oncogenicity.

Authors:  C J Der; A D Cox
Journal:  Cancer Cells       Date:  1991-09

10.  Chaetomella acutiseta produces chaetomellic acids A and B which are reversible inhibitors of farnesyl-protein transferase.

Authors:  R B Lingham; K C Silverman; G F Bills; C Cascales; M Sanchez; R G Jenkins; S E Gartner; I Martin; M T Diez; F Peláez
Journal:  Appl Microbiol Biotechnol       Date:  1993-11       Impact factor: 4.813

View more
  2 in total

1.  Discovery of the actinoplanic acid pathway in Streptomyces rapamycinicus reveals a genetically conserved synergism with rapamycin.

Authors:  Peter Mrak; Philipp Krastel; Petra Pivk Lukančič; Jianshi Tao; Dominik Pistorius; Charles M Moore
Journal:  J Biol Chem       Date:  2018-10-16       Impact factor: 5.157

Review 2.  An overview on natural farnesyltransferase inhibitors for efficient cancer therapy.

Authors:  Xiaohan Dai; Yingni Sun; Ting Zhang; Yongfei Ming; Gao Hongwei
Journal:  J Enzyme Inhib Med Chem       Date:  2020-12       Impact factor: 5.051

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.